Literature DB >> 23178752

TNF-α is essential in the induction of fatal autoimmune hepatitis in mice through upregulation of hepatic CCL20 expression.

Satoru Iwamoto1, Masahiro Kido, Nobuhiro Aoki, Hisayo Nishiura, Ryutaro Maruoka, Aki Ikeda, Taku Okazaki, Tsutomu Chiba, Norihiko Watanabe.   

Abstract

It is unclear what roles TNF-α has in the development of autoimmune hepatitis (AIH) and whether AIH is responsive to anti-TNF-α. We recently developed a mouse model of fatal AIH that develops in PD-1-deficient mice thymectomized three days after birth, finding that CCR6-CCL20 axis-dependent migration of dysregulated splenic T cells is crucial to induce AIH. In this study, we show the indispensable role of TNF-α in the development of AIH. Administering anti-TNF-α prevented the induction, but treatment by anti-TNF-α after the induction did not suppress progression. Administering anti-TNF-α did not prevent splenic T-cell activation, but did suppress hepatic CCL20 expression. In contrast, administering anti-CCL20 suppressed AIH but not elevated serum TNF-α levels. TNF-α stimulation enhanced CCL20 expression in hepatocytes. These findings suggest that TNF-α is essential in the induction of AIH through upregulation of hepatic CCL20 expression, which allows migration of dysregulated splenic T cells.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23178752     DOI: 10.1016/j.clim.2012.10.008

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  14 in total

Review 1.  Preterm birth and single nucleotide polymorphisms in cytokine genes.

Authors:  Qin Zhu; Jian Sun; Ying Chen
Journal:  Transl Pediatr       Date:  2014-04

Review 2.  Non-alcoholic fatty liver disease and psoriasis: So far, so near.

Authors:  Giulia Ganzetti; Anna Campanati; Annamaria Offidani
Journal:  World J Hepatol       Date:  2015-03-27

3.  Modeling toxicodynamic effects of trichloroethylene on liver in mouse model of autoimmune hepatitis.

Authors:  Kathleen M Gilbert; Brad Reisfeld; Todd J Zurlinden; Meagan N Kreps; Stephen W Erickson; Sarah J Blossom
Journal:  Toxicol Appl Pharmacol       Date:  2014-07-12       Impact factor: 4.219

4.  Synergistic effect of interleukin-17 and tumour necrosis factor-α on inflammatory response in hepatocytes through interleukin-6-dependent and independent pathways.

Authors:  A Beringer; N Thiam; J Molle; B Bartosch; P Miossec
Journal:  Clin Exp Immunol       Date:  2018-05-31       Impact factor: 4.330

Review 5.  Autoimmune hepatitis, one disease with many faces: etiopathogenetic, clinico-laboratory and histological characteristics.

Authors:  Nikolaos K Gatselis; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  World J Gastroenterol       Date:  2015-01-07       Impact factor: 5.742

6.  Belimumab is a promising third-line treatment option for refractory autoimmune hepatitis.

Authors:  Pinelopi Arvaniti; George Giannoulis; Stella Gabeta; Kalliopi Zachou; George K Koukoulis; George N Dalekos
Journal:  JHEP Rep       Date:  2020-05-29

7.  Misoprostol modulates cytokine expression through a cAMP pathway: Potential therapeutic implication for liver disease.

Authors:  Leila Gobejishvili; Smita Ghare; Rehan Khan; Alexander Cambon; David F Barker; Shirish Barve; Craig McClain; Daniell Hill
Journal:  Clin Immunol       Date:  2015-09-25       Impact factor: 3.969

Review 8.  Natural killer T (NKT) cells in autoimmune hepatitis.

Authors:  Jochen Mattner
Journal:  Curr Opin Immunol       Date:  2013-10-19       Impact factor: 7.486

9.  Autoimmune Hepatitis Triggered by Anti-TNF-α Therapy.

Authors:  Satoshi Nakayama
Journal:  Case Rep Med       Date:  2013-09-08

10.  Transgenic mouse model harboring the transcriptional fusion ccl20-luciferase as a novel reporter of pro-inflammatory response.

Authors:  Martina Crispo; Laurye Van Maele; Julien Tabareau; Delphine Cayet; Agustina Errea; Ana María Ferreira; Martin Rumbo; Jean Claude Sirard
Journal:  PLoS One       Date:  2013-11-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.